Vaccine effectiveness

against symptomatic disease

100 unvaccinated people who would have developed symptoms after a Covid infection

35%

After dose one

79%

After dose two

Protected against

developing symptoms

Not protected

Vaccine effectiveness

against hospitalisation

100 unvaccinated people who would have been hospitalised after a Covid infection

80%

After dose one

96%

After dose two

Protected against

hospitalisation

Not protected

Vaccine effectiveness

against symptomatic disease

Vaccine effectiveness

against hospitalisation

100 unvaccinated people who would have developed symptoms after a Covid infection

100 unvaccinated people who would have been hospitalised after a Covid infection

35%

After dose one

79%

After dose two

80%

After dose one

96%

After dose two

Protected against

developing symptoms

Protected against

hospitalisation

Not protected

Not protected